Why You Should Attend:
This two day conference will enable attendees to streamline risk mitigation and improve drug safety by leveraging tools and technologies and interpreting developments in regulatory compliance. The 7thinstallment of Pharmacovigilance, Drug Safety & Risk Management will focus on improving PV strategies to enable predictive drug safety in order to increase patient safety, and decrease drug risk potential.
Develop more proficient and profound pharmacovigilance strategies to utilize throughout product lifecycle. Streamline drug safety and regulatory approval process and increase patient voluntary reporting.
Anders Lindholm MD, PhD
Vice President, Head of Drug Safety Inflammation & Immunology
Senior Vice President, Head Global Drug Safety
John Price, MD PhD
Vice President, Global Pharmacovigilance and Drug Safety
Alexion Pharmaceuticals, Inc
Vice President Pharmacovigilance
Alexandre Kiazand, M.D.
Head Safety Science